This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  83R5029 JSC-D
 
  By: Huffman S.B. No. 263
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the designation of certain synthetic cannabinoids as
  controlled substances and controlled substance analogues under the
  Texas Controlled Substances Act.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 481.002, Health and Safety Code, is
  amended by amending Subdivision (6) and adding Subdivision (54) to
  read as follows:
               (6)  "Controlled substance analogue" means:
                     (A)  a substance with a chemical structure
  substantially similar to the chemical structure of a controlled
  substance in Schedule I or II or Penalty Group 1, 1-A, [or] 2, or
  2-A; or
                     (B)  a substance specifically designed to produce
  an effect substantially similar to, or greater than, the effect of a
  controlled substance in Schedule I or II or Penalty Group 1, 1-A,
  [or] 2, or 2-A.
               (54)  "Isostere" means a chemical compound that is
  structurally derived from another chemical compound by:
                     (A)  substitution of an atom or group of atoms in
  or on a chain or cyclic structure with a different atom or group of
  atoms;
                     (B)  addition of one or more atoms to or within a
  chain or cyclic structure;
                     (C)  elision of one or more atoms from a chain or
  cyclic structure;
                     (D)  changing the degree or position of
  unsaturation in a chain or cyclic structure; or
                     (E)  any combination of modifications described
  by Paragraph (A), (B), (C), or (D).
         SECTION 2.  Section 481.1031, Health and Safety Code, is
  amended to read as follows:
         Sec. 481.1031.  PENALTY GROUP 2-A.  Penalty Group 2-A
  consists of any quantity of a synthetic chemical compound that is a
  cannabinoid receptor agonist [and mimics the pharmacological
  effect of naturally occurring cannabinoids], including:
               (1)  compounds [naphthoylindoles] structurally derived
  from indole or from any isostere of indole [3-(1-naphthoyl)indole]
  by substitution at both the 1-position [nitrogen atom] of the
  indole ring system with any [by] alkyl group, cycloalkyl group, or
  (cycloalkyl)alkyl group, or with an isostere or derivative of any
  of these groups, and the 3-position of the indole ring system with
  any alkyl group, cycloalkyl group, or (cycloalkyl)alkyl group, or
  with an isostere or derivative of any of these groups, regardless of
  [, alkenyl, cycloalkylmethyl, cycloalkylethyl, or
  2-(4-morpholinyl)ethyl,] whether the indole ring system is [or not]
  further substituted [in the indole ring] to any extent at other ring
  system positions by additional groups, such as [, whether or not
  substituted in the napthyl ring to any extent, including]:
                     AKB-48;
                     AM-679;
                     AM-694;
                     AM-1235;
                     AM-1241;
                     AM-2201;
                     AM-2232;
                     EAM-2201;
                     JWH-004;
                     JWH-007;
                     JWH-009;
                     JWH-015;
                     JWH-016;
                     JWH-018;
                     JWH-019;
                     JWH-020;
                     JWH-046;
                     JWH-047;
                     JWH-048;
                     JWH-049;
                     JWH-050;
                     JWH-073;
                     JWH-076;
                     JWH-079;
                     JWH-080;
                     JWH-081;
                     JWH-082;
                     JWH-083;
                     JWH-093;
                     JWH-094;
                     JWH-095;
                     JWH-096;
                     JWH-097;
                     JWH-098;
                     JWH-099;
                     JWH-100;
                     JWH-116;
                     JWH-122;
                     JWH-148;
                     JWH-149;
                     JWH-153;
                     JWH-159;
                     JWH-164;
                     JWH-165;
                     JWH-166;
                     JWH-167;
                     JWH-171;
                     JWH-172;
                     JWH-173;
                     JWH-175;
                     JWH-176;
                     JWH-180;
                     JWH-181;
                     JWH-182;
                     JWH-184;
                     JWH-185;
                     JWH-189;
                     JWH-192;
                     JWH-193;
                     JWH-194;
                     JWH-195;
                     JWH-196;
                     JWH-197;
                     JWH-198;
                     JWH-199;
                     JWH-200;
                     JWH-203;
                     JWH-204;
                     JWH-205;
                     JWH-206;
                     JWH-208;
                     JWH-210;
                     JWH-211;
                     JWH-212;
                     JWH-213;
                     JWH-234;
                     JWH-235;
                     JWH-237;
                     JWH-239;
                     JWH-240;
                     JWH-241;
                     JWH-242;
                     JWH-248;
                     JWH-249;
                     JWH-250;
                     JWH-251;
                     JWH-252;
                     JWH-253;
                     JWH-258;
                     JWH-259;
                     JWH-260;
                     JWH-262;
                     JWH-267;
                     JWH-302;
                     JWH-303;
                     JWH-305;
                     JWH-306;
                     JWH-311;
                     JWH-312;
                     JWH-313;
                     JWH-314;
                     JWH-315;
                     JWH-386;
                     JWH-387;
                     JWH-394;
                     JWH-395;
                     JWH-397;
                     JWH-398;
                     JWH-399;
                     JWH-400;
                     JWH-412;
                     JWH-413; [and]
                     JWH-414;
                     MAM-2201;
                     UR-144; and
                     XLR-11;
               (2)  compounds [naphthylmethylindones structurally
  derived from 1H-indol-3-yl-(1-naphthyl)methane by substitution at
  the nitrogen atom of the indole ring by alkyl, alkenyl,
  cycloalkylmethyl, cycloalkylethyl, or 2-(4-morpholinyl)ethyl,
  whether or not further substituted in the indole ring to any extent,
  whether or not substituted in the naphthyl ring to any extent,
  including:
                     [JWH-175;
                     [JWH-184;
                     [JWH-185;
                     [JWH-192;
                     [JWH-194;
                     [JWH-195;
                     [JWH-196;
                     [JWH-197; and
                     [JWH-199;
                     [naphthoylpyrroles] structurally derived from
  pyrrole or from any isostere of pyrrole [3-(1-naphthoyl)pyrrole] by
  substitution at both the 1-position [nitrogen atom] of the pyrrole
  ring system with any [by] alkyl group, cycloalkyl group, or
  (cycloalkyl)alkyl group, or with an isostere or derivative of any
  of these groups, and the 3-position of the pyrrole ring system with
  any alkyl group, cycloalkyl group, or (cycloalkyl)alkyl group, or
  with an isostere or derivative of any of these groups, regardless
  of[, alkenyl, cycloalkylmethyl, cycloalkylethyl, or
  2-(4-morpholinyl)ethyl,] whether the pyrrole ring system is [or
  not] further substituted [in the pyrrole ring] to any extent at
  other ring system positions by additional groups, such as[, whether
  or not substituted in the naphthyl ring to any extent, including]:
                     JWH-030;
                     JWH-145;
                     JWH-146;
                     JWH-147;
                     JWH-150;
                     JWH-156;
                     JWH-243;
                     JWH-244;
                     JWH-245;
                     JWH-246;
                     JWH-292;
                     JWH-293;
                     JWH-307;
                     JWH-308;
                     JWH-309;
                     JWH-346;
                     JWH-347;
                     JWH-348;
                     JWH-363;
                     JWH-364;
                     JWH-365;
                     JWH-366;
                     JWH-367;
                     JWH-368;
                     JWH-369;
                     JWH-370;
                     JWH-371;
                     JWH-372;
                     JWH-373; and
                     JWH-392;
               (3)  compounds [naphthylmethylindenes structurally
  derived from 1-(1-naphthylmethyl)indene by substitution at the
  3-position of the indene ring by alkyl, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
  substituted in the indene ring to any extent, whether or not
  substituted in the naphthyl ring to any extent, including:
                     [JWH-171;
                     [JWH-172;
                     [JWH-173; and
                     [JWH-176;
               [phenylacetylindoles structurally derived from
  3-phenylacetylindole by substitution at the nitrogen atom of the
  indole ring with alkyl, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
  substituted in the indole ring to any extent, whether or not
  substituted in the phenyl ring to any extent, including:
                     [AM-694;
                     [AM-1241;
                     [JWH-167;
                     [JWH-203;
                     [JWH-204;
                     [JWH-205;
                     [JWH-206;
                     [JWH-208;
                     [JWH-237;
                     [JWH-248;
                     [JWH-249;
                     [JWH-250;
                     [JWH-251;
                     [JWH-252;
                     [JWH-253;
                     [JWH-302;
                     [JWH-303;
                     [JWH-305;
                     [JWH-306;
                     [JWH-311;
                     [JWH-312;
                     [JWH-313;
                     [JWH-314; and
                     [JWH-315;
               [cyclohexylphenols] structurally derived from
  2-cyclohexylphenol, or from any isostere of 2-cyclohexylphenol,
  [2-(3-hydroxycyclohexyl)phenol] by substitution at the 5-position
  of the phenyl [phenolic] ring with any [by] alkyl group, a
  cycloalkyl group, or a (cycloalkyl)alkyl group, or with an isostere
  of any of these groups[, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl], regardless of whether
  further [or not] substituted in the cyclohexyl ring or in the phenyl
  ring to any extent, such as [including]:
                     CP-55,940;
                     CP-47,497;
                     analogues of CP-47,497, including VII, V, VIII, I,
  II, III, IV, IX, X, XI, XII, XIII, XV, and XVI;
                     JWH-337;
                     JWH-344;
                     JWH-345; and
                     JWH-405; and
               (4)  cannabinol derivatives, except where contained in
  marihuana, including tetrahydro derivatives of cannabinol and
  3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
  such as:
                     Nabilone;
                     HU-210;
                     HU-211; and
                     WIN-55,212-2.
         SECTION 3.  Section 481.106, Health and Safety Code, is
  amended to read as follows:
         Sec. 481.106.  CLASSIFICATION OF CONTROLLED SUBSTANCE
  ANALOGUE. For the purposes of the prosecution of an offense under
  this subchapter involving the manufacture, delivery, or possession
  of a controlled substance, Penalty Groups 1, 1-A, [and] 2, and 2-A
  include a controlled substance analogue that:
               (1)  has a chemical structure substantially similar to
  the chemical structure of a controlled substance listed in the
  applicable penalty group; or
               (2)  is specifically designed to produce an effect
  substantially similar to, or greater than, a controlled substance
  listed in the applicable penalty group.
         SECTION 4.  The change in law made by this Act applies only
  to an offense committed on or after the effective date of this Act.
  An offense committed before the effective date of this Act is
  governed by the law in effect on the date the offense was committed,
  and the former law is continued in effect for that purpose. For
  purposes of this section, an offense was committed before the
  effective date of this Act if any element of the offense occurred
  before that date.
         SECTION 5.  This Act takes effect September 1, 2013.